Viewing Study NCT00167167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-01-29 @ 12:15 PM
Study NCT ID: NCT00167167
Status: COMPLETED
Last Update Posted: 2017-11-29
First Post: 2005-09-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Chronic View
None AML View
None MDS View
None Leukemia, Lymphocytic, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Donor Lymphocyte Infusion View
None relapse View
None post-transplant View